Gene · 1366
Papers1,866
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,866
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting the effect of ileal faecal diversion on the intestine using single-cell sequencing. | Clin Transl Med | 2023 | 37400975 | PubTator, text mining | PubMed |
| Trophoblast cell surface antigen-2 phosphorylation triggered by binding of galectin-3 drives metastasis through down-regulation of E-cadherin. | J Biol Chem | 2023 | 37380081 | PubTator, text mining | PubMed |
| scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content. | Cells | 2023 | 37371048 | PubTator, text mining | PubMed |
| The early impact of diets enriched with saturated and unsaturated fatty acids on intestinal inflammation and tight junctions. | J Nutr Biochem | 2023 | 37364793 | PubTator, text mining | PubMed |
| β-Glucan-Mediated Oral Codelivery of 5FU and Bcl2 siRNA Attenuates Stomach Cancer. | ACS Appl Mater Interfaces | 2023 | 37350332 | PubTator, text mining | PubMed |
| Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer. | Natl Sci Rev | 2023 | 37347037 | PubTator, text mining | PubMed |
| Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer. | Oncogene | 2023 | 37344626 | PubTator, text mining | PubMed |
| Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis. | Nutrients | 2023 | 37299554 | PubTator, text mining | PubMed |
| Fecal and Circulating Biomarkers for the Non-Invasive Assessment of Intestinal Permeability. | Diagnostics (Basel) | 2023 | 37296827 | PubTator, text mining | PubMed |
| Hazara orthonairovirus nucleoprotein facilitates viral cell-to-cell spread by modulating tight junction protein, claudin-1. | Front Microbiol | 2023 | 37287449 | PubTator, text mining | PubMed |
| The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7. | Biol Pharm Bull | 2023 | 37286513 | PubTator, text mining | PubMed |
| Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier. | Ther Adv Gastroenterol | 2023 | 37274298 | PubTator, text mining | PubMed |
| Deterministic evolution and stringent selection during preneoplasia. | Nature | 2023 | 37258665 | PubTator, text mining | PubMed |
| Gene knockout inference with variational graph autoencoder learning single-cell gene regulatory networks. | Nucleic Acids Res | 2023 | 37246643 | PubTator, text mining | PubMed |
| Antibody-Loaded Nanoplatforms for Colorectal Cancer Diagnosis and Treatment: An Update. | Pharmaceutics | 2023 | 37242756 | PubTator, text mining | PubMed |
| Claudin Barriers on the Brink: How Conflicting Tissue and Cellular Priorities Drive IBD Pathogenesis. | Int J Mol Sci | 2023 | 37239907 | PubTator, text mining | PubMed |
| Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2023 | 37239838 | PubTator, text mining | PubMed |
| Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer. | Biology (Basel) | 2023 | 37237509 | PubTator, text mining | PubMed |
| Apposition of Fibroblasts With Metaplastic Gastric Cells Promotes Dysplastic Transition. | Gastroenterology | 2023 | 37196797 | PubTator, text mining | PubMed |
| Editorial: Role of matrix metalloproteinases and other inflammatory mediators in the disruption of the intestinal tight junction barrier. | Front Immunol | 2023 | 37180145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1366/papers?page=9